Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Is ‘One to Watch’
Operator of flagship Waterberg PGM Project located in South Africa, which is home to 70% of platinum and 35% of…
Blog
QualityStocksNewsBreaks – HealthLynked Corp. (HLYK) Announces Q2, H1 2024 Financial Results Reflecting Efforts to Streamline Operations
HealthLynked (OTCQB: HLYK), a trailblazer in healthcare technology, today announced financial results for its Q2 and H1 2024 ending June…
QualityStocksNewsBreaks – Starco Brands Inc. (STCB) Board Approves Insider Trading Policy, Shares Plans to Buy Back Stock
Starco Brands (OTCQB: STCB), a developer and acquirer of behavior-changing technologies and brands that spark excitement in the everyday, has…
D-Wave Quantum Inc. (NYSE: QBTS) Expands Product Roadmap to Bring Power of Quantum to Artificial Intelligence & Machine Learning
Expanded product roadmap to enhance D-Wave’s Leap(TM) quantum cloud service and bring new Quantum AI solutions to market Initiative targets…
QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Announces Completion of Name Change, Begins Trading Under New Symbol
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM), formerly FSD Pharma Inc., a biopharmaceutical company dedicated to building a portfolio of…
QualityStocksNewsBreaks – Actuate Therapeutics, Inc. (NASDAQ: ACTU) Closes on $22.4M Initial Public Offering
Actuate Therapeutics (NASDAQ: ACTU), a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult…
QualityStocksNewsBreaks – Golden Triangle Ventures Inc. (GTVH), Saxon Capital Group Partner to Bring ‘Groundbreaking’ Solar Glass Technology to Destino Ranch
Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, today announced a strategic partnership with Saxon Capital Group Inc. (OTC:…
QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in…
QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q2 2024 Financial Results, Shares Business Update
Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO…
Nightfood Holdings Inc. (NGTF): The Power of Portfolio Diversification
Nightfood is blowing up TikTok with its sleep-friendly cookies for nighttime snackers 2024 has been a transformational year, as Nightfood…